Structures by: Doumbia M. L.
Total: 7
3-Hydroxy-4-phenyl-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepin-2-one
C15H14N2O2
IUCrData (2016) 1, 11 x161879
a=5.519(2)Å b=21.594(8)Å c=9.917(4)Å
α=90° β=90.405(5)° γ=90°
(3<i>S</i>,4<i>S</i>)-1-Benzyl-3-hydroxy-4-phenyl-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepin-2-one
C22H20N2O2
IUCrData (2016) 1, 11 x161849
a=8.9169(2)Å b=17.6360(5)Å c=11.7937(3)Å
α=90° β=109.1990(10)° γ=90°
5-Methyl-3-[1-(2-pyridylmethyl)-1<i>H</i>-benzimidazol-2-ylmethyl]isoxazole
C18H16N4O
Acta Crystallographica Section E (2009) 65, 11 o2714-o2715
a=11.0761(2)Å b=8.65350(10)Å c=16.5920(3)Å
α=90.0° β=103.1360(10)° γ=90.0°
<i>N</i>-(5-Phenyl-1<i>H</i>-pyrazol-3-yl)benzene-1,2-diamine
C15H14N4
Acta Crystallographica Section E (2010) 66, 4 o841
a=13.2357(8)Å b=5.8473(4)Å c=16.4039(10)Å
α=90.00° β=92.074(4)° γ=90.00°
3-{2-[(3-Phenylquinoxalin-2-yl)oxy]ethyl}-1,3-oxazolidin-2-one
C19H17N3O3
Acta Crystallographica Section E (2011) 67, 5 o1235
a=10.1392(4)Å b=9.1398(4)Å c=34.8462(15)Å
α=90.00° β=90.00° γ=90.00°
1-Phenyl-3<i>H</i>-2,3-benzodiazepin-4(5<i>H</i>)-one
C15H12N2O
Acta Crystallographica Section E (2012) 68, 8 o2443
a=5.47180(10)Å b=8.40200(10)Å c=26.3250(5)Å
α=90.00° β=90.00° γ=90.00°
3-[2-(3-Phenyl-2-oxo-1,2-dihydroquinoxalin-1-yl)ethyl]-1,3-oxazolidin-2-one
C19H17N3O3
Acta Crystallographica Section E (2013) 69, 5 o662
a=9.6314(5)Å b=16.6596(9)Å c=10.0749(5)Å
α=90.00° β=98.097(3)° γ=90.00°